In 2021, we said goodbye to the European Group for Generic Veterinary Products and began a new era as Access VetMed to acknowledge our members’ increasing activity in added value medicines.

We also published our second market survey in September which showed that the generics industry is very active in the market supplying over half of the new product registrations. The companies also continued investing in R&D to bring products that are specifically fit-for-purpose.

Most of our resources were focused on facilitating the industry’s smooth transition to the new EU legislation by solving issues with the regulators and keeping our members fully informed through a growing number of online trainings and learning tools.

We hope you enjoy the read!

Access VetMed activity report 2021